NOK:NYSENokia Corporation Sponsored Analysis
Data as of 2026-06-02 - not real-time
$16.25
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical momentum is firmly bullish – the price sits above the 20‑day (14.22), 50‑day (11.53) and 200‑day (7.52) SMAs, RSI is at 67, and MACD shows a bullish crossover with a positive histogram. However, valuation metrics signal severe overpricing: the trailing P/E of 101× dwarfs the industry average of ~43×, the DCF‑derived fair value (~$4.65) is less than a third of the current $16.25 price, and the upside/downside estimate is –20.6%. Volatility is high at ~78% over 30 days and beta is ~1.18, indicating sensitivity to market swings. The dividend yield of just over 1% is backed by a payout ratio near 100%, raising sustainability concerns.
On the fundamentals side, revenue grew modestly 2.4% YoY with gross margin ~45% and operating margin ~5.3%, while cash ($5.83 bn) comfortably exceeds debt ($3.32 bn). Recent news highlights a surge in AI and cloud infrastructure demand and analyst upgrades to “Buy,” but the consensus one‑year price target ($7.95) remains far below the market price, reflecting skepticism about near‑term upside.
On the fundamentals side, revenue grew modestly 2.4% YoY with gross margin ~45% and operating margin ~5.3%, while cash ($5.83 bn) comfortably exceeds debt ($3.32 bn). Recent news highlights a surge in AI and cloud infrastructure demand and analyst upgrades to “Buy,” but the consensus one‑year price target ($7.95) remains far below the market price, reflecting skepticism about near‑term upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance level (~$16.63)
- Bullish technicals but high volatility
- Severe valuation gap vs DCF
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Growing AI/cloud infrastructure demand
- Analyst upgrades and positive sentiment
- Strong cash position to fund growth
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Unsustainable dividend payout ratio
- Persistently high valuation multiples
- Moderate ROE/ROA and sector cyclicality
Key Metrics & Analysis
Financial Health
Revenue Growth2.40%
Profit Margin3.98%
P/E Ratio101.6
ROE3.72%
ROA2.76%
Debt/Equity15.63
P/B Ratio3.7
Op. Cash Flow$2.0B
Free Cash Flow$1.6B
Industry P/E42.9
Technical Analysis
TrendBullish
RSI67.0
Support$12.13
Resistance$16.63
MA 20$14.22
MA 50$11.53
MA 200$7.52
MACDBullish
VolumeStable
Fear & Greed Index92.64
Valuation
Fair Value$4.65
Target Price$12.90
Upside/Downside-20.62%
GradeOvervalued
TypeGrowth
Dividend Yield1.01%
Risk Assessment
Beta1.18
Volatility77.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.